Chemoinformaics analysis of 3-Tetradecynoic acid
| Molecular Weight | 224.344 | nRot | 9 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 1 |
| Exact Molecular Weight | 224.178 | nRing | 0 |
| Solubility: LogS | -0.531 | nHRing | 0 |
| Solubility: LogP | 1.116 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 40.987 |
| nHD | 1 | BPOL | 24.945 |
| QED | 0.462 |
| Synth | 3.325 |
| Natural Product Likeliness | 1.884 |
| NR-PPAR-gamma | 0.456 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.276 |
| MDCK | 0.0000309 |
| BBB | 0.98 |
| PPB | 0.412158 |
| VDSS | 1.885 |
| FU | 0.734449 |
| CYP1A2-inh | 0.181 |
| CYP1A2-sub | 0.503 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.739 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.218 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.379 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.254 |
| CL | 9.973 |
| T12 | 0.815 |
| hERG | 0.042 |
| Ames | 0.049 |
| ROA | 0.031 |
| SkinSen | 0.954 |
| Carcinogencity | 0.045 |
| EI | 0.996 |
| Respiratory | 0.809 |
| NR-Aromatase | 0.013 |
| Antiviral | Yes |
| Prediction | 0.784108 |